Hydrap-ES en es it fr

Hydrap-ES Brand names, Hydrap-ES Analogs

Hydrap-ES Brand Names Mixture

  • Hydropres 25 Tab (Hydrochlorothiazide + Reserpine)
  • Hydropres 50 Tab (Hydrochlorothiazide + Reserpine)
  • SER-AP-ES Tab (Hydralazine Hydrochloride + Hydrochlorothiazide + Reserpine)

Hydrap-ES Chemical_Formula


Hydrap-ES RX_link

No information avaliable

Hydrap-ES fda sheet

Hydrap-ES msds (material safety sheet)

Hydrap-ES MSDS

Hydrap-ES Synthesis Reference

No information avaliable

Hydrap-ES Molecular Weight

608.679 g/mol

Hydrap-ES Melting Point

264.5 oC

Hydrap-ES H2O Solubility

73 mg/L

Hydrap-ES State


Hydrap-ES LogP


Hydrap-ES Dosage Forms


Hydrap-ES Indication

Foe the treatment of hypertension

Hydrap-ES Pharmacology

Reserpine is an adrenergic blocking agent used to treat mild to moderate hypertension via the disruption of norepinephrine vesicular storage. The antihypertensive actions of Reserpine are a result of its ability to deplete catecholamines from peripheral sympathetic nerve endings. These substances are normally involved in controlling heart rate, force of cardiac contraction and peripheral resistance.

Hydrap-ES Absorption

No information avaliable

Hydrap-ES side effects and Toxicity

Possible human carcinogen. May cause reproductive harm. ORL-RAT LD50 420 mg/kg; IPR-RAT LD50 44 mg/kg; IVN-RAT LD50 15 mg/kg; ORL-MUS LD50 200 mg/kg; SCU-MUS LD50 52 mg/kg; IPR-RBT LD50 7 mg/kg

Hydrap-ES Patient Information

No information avaliable

Hydrap-ES Organisms Affected

Humans and other mammals